Literature DB >> 7642890

Neurobehavioral and neurologic outcome in long-term survivors of posterior fossa brain tumors: role of age and perioperative factors.

C A Chapman1, D P Waber, J H Bernstein, S L Pomeroy, B LaVally, S E Sallan, N Tarbell.   

Abstract

We evaluated the neuropsychological and neurologic outcome of 15 long-term survivors of posterior fossa tumors who were treated between 1970 and 1984 with cranial irradiation (n = 15) and surgery (n = 14). The interval between diagnosis and evaluation ranged from 4 to 20 years (median = 10 years). Earlier age at diagnosis (< 6 years) was associated with an increased incidence of severe neurologic and neuropsychological sequelae. Hydrocephalus, obtundation, and tumor extension outside the vermis also were more prevalent in the younger group. Poor neurobehavioral outcomes in young children with posterior fossa tumors may be related to more aggressive tumor growth or complications of the initial therapy and not solely due to toxicity from craniospinal irradiation.

Entities:  

Mesh:

Year:  1995        PMID: 7642890     DOI: 10.1177/088307389501000308

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  13 in total

1.  Neurological dysfunction associated with postoperative cerebellar mutism.

Authors:  J Siffert; T Y Poussaint; L C Goumnerova; R M Scott; B LaValley; N J Tarbell; S L Pomeroy
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

Review 2.  Neuropsychological sequelae and quality of life following treatment of posterior fossa ependymomas in children.

Authors:  Constantinos Charalambides; Argyris Dinopoulos; Spyros Sgouros
Journal:  Childs Nerv Syst       Date:  2009-06-25       Impact factor: 1.475

3.  The microtubule stabilizer patupilone (epothilone B) is a potent radiosensitizer in medulloblastoma cells.

Authors:  Christoph Oehler; André O von Bueren; Polina Furmanova; Angela Broggini-Tenzer; Katrin Orlowski; Stefan Rutkowski; Karl Frei; Michael A Grotzer; Martin Pruschy
Journal:  Neuro Oncol       Date:  2011-07-09       Impact factor: 12.300

4.  Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children's Oncology Group.

Authors:  C Kretschmar; L Kleinberg; M Greenberg; P Burger; Emi Holmes; M Wharam
Journal:  Pediatr Blood Cancer       Date:  2007-03       Impact factor: 3.167

5.  Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial.

Authors:  Girish Dhall; Sharon H O'Neil; Lingyun Ji; Kelley Haley; Ashley M Whitaker; Marvin D Nelson; Floyd Gilles; Sharon L Gardner; Jeffrey C Allen; Albert S Cornelius; Kamnesh Pradhan; James H Garvin; Randal S Olshefski; Juliette Hukin; Melanie Comito; Stewart Goldman; Mark P Atlas; Andrew W Walter; Stephen Sands; Richard Sposto; Jonathan L Finlay
Journal:  Neuro Oncol       Date:  2020-12-18       Impact factor: 12.300

6.  Neuropsychological sequelae of the treatment of children with medulloblastoma.

Authors:  M Dennis; B J Spiegler; C R Hetherington; M L Greenberg
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

7.  Neurocognitive function in same-sex twins following focal radiation for medulloblastoma.

Authors:  Donald J Mabbott; Marcia Barnes; Normand Laperriere; Susan H Landry; Eric Bouffet
Journal:  Neuro Oncol       Date:  2007-08-17       Impact factor: 12.300

8.  Carboplatin-based primary chemotherapy for infants and young children with CNS tumors.

Authors:  Maryam Fouladi; Sri Gururangan; Albert Moghrabi; Peter Phillips; Lindsey Gronewold; Dana Wallace; Robert A Sanford; Amar Gajjar; Larry E Kun; Richard Heideman
Journal:  Cancer       Date:  2009-07-15       Impact factor: 6.860

9.  Physical functioning in pediatric survivors of childhood posterior fossa brain tumors.

Authors:  P Janine Piscione; Eric Bouffet; Donald J Mabbott; Iffat Shams; Abhaya V Kulkarni
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

10.  Evolution of neurological impairment in pediatric infratentorial ependymoma patients.

Authors:  E Brannon Morris; Chenghong Li; Raja B Khan; Robert A Sanford; Frederick Boop; Renee Pinlac; Xiaoping Xiong; Thomas E Merchant
Journal:  J Neurooncol       Date:  2009-03-29       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.